Trade AbbVie ^ABBV

AbbVie Inc. $ABBV Stock Sold by Greenup Street Wealth Management LLC - Markets Daily

Raleigh Capital Management Inc. Sells 3,794 Shares of AbbVie Inc. $ABBV

Is Earnings Beat Altering The Investment Case For AbbVie Stock (ABBV)?

AbbVie Inc. $ABBV Stock Sold by VIRGINIA RETIREMENT SYSTEMS ET Al - Markets Daily

AbbVie Increases Profit Outlook Due to Surge in Immunology Drug Sales, ETPharma

Health Care Up on Defensive Rotation - Health Care Roundup | Morningstar

Q3 earnings round-up: AstraZeneca, AbbVie, Kenvue

AbbVie Scores Win in Fight Over Botox Selected for US Price Cuts

AbbVie (NYSE:ABBV) Releases Earnings Results, Beats Estimates By $0.09 EPS

AbbVie Stocks Rise 1.75% With Two Medicines Providing Nearly Half of Revenue

What AbbVie (ABBV) Said on Its Q3 Earnings Call

AbbVie (NYSE: ABBV) raises its profit outlook as immunology sales jump 16.3% - Stock Observer

AbbVie Lifts 2026 Outlook as Immunology, Neuroscience Quarterly Sales Beat Views

AbbVie Inc. (ABBV) Stock: Rise as Q3 Revenue Jumps 10.3% and EPS Tops $3.82

$250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends

CDs Offer Fixed Interest. AbbVie Offers a Growing Dividend. Which Should Retirees Choose?

Stock Market Today: Nasdaq Futures Plunge 2% as Big Tech Sells Off

Since HDV Switched to Monthly Pay, Here's What's Changed for Income Investors - 24/7 Wall St.

AbbVie (NYSE:ABBV) Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS - Daily Political

AbbVie beats estimates but stock dips

AbbVie Is Up 10% in a Month to a 52-Week High: Is There "More Room for Multiple Expansion"?

AbbVie Raises FY26 Adj. EPS Outlook; Boost Dividend 5.2% - Update

AbbVie 3Q Revenue Rises on Strength in Immunology, Neuroscience | Morningstar

AbbVie Q3 Income Advances

Soltis Investment Advisors LLC Acquires 12,825 Shares of AbbVie Inc. $ABBV

4,523 Shares in AbbVie Inc. $ABBV Acquired by Livelsberger Financial Advisory

AbbVie Inc. $ABBV Stake Lessened by Everett Harris & Co. CA

AbbVie Inc. $ABBV Stake Boosted by Choreo LLC

AbbVie Inc. $ABBV Stock Holdings Raised by China Universal Asset Management Co. Ltd.

AbbVie News | Markets Insider

AbbVie (ABBV) Stock Still Looks Cheap On Its 197% Five Year Run

Alphabet's Record Plunge Drags Down Tech as the Rest of the Market Rallies

0% Above Fair Value? AbbVie (ABBV) On Fresh Qulipta Phase 3 Data

AbbVie Stock: What 10 Years of Growth and Dividends Did for $1,000

AbbVie (NYSE:ABBV) Sets New 1-Year High - Here's What Happened

4 Reliable Dividend Stocks, Led by UPS, to Build Lifetime Passive Income

AbbVie's QULIPTA Outperforms Topiramate In Phase 3 Migraine Prevention Study

AbbVie Inc. $ABBV Shares Sold by LaFleur & Godfrey LLC

AbbVie TEMPLE Study Demonstrates Superior Tolerability and Efficacy of Atogepant (QULIPTA®) in Head-to-Head Migraine Prevention Trial

3,985 AbbVie Inc. $ABBV Shares Bought by Sowell Financial Services LLC

AbbVie Inc. $ABBV Shares Sold by BLB&B Advisors LLC

Follicular Lymphoma Clinical Trial Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight | ABNewswire

AbbVie (ABBV) Seeks FDA Approval For Etentamig In Multiple Myeloma

AbbVie's BOTOX Cosmetic Day Returns November 18 With Special Offers

Why JEPI's Total Return Has Outpaced Its Payout

AbbVie Inc. $ABBV Stock Purchased by Sigma Investment Counselors Inc.

The Countdown Is On: BOTOX® Cosmetic (onabotulinumtoxinA) Day is Back Nov. 18 | Morningstar

Retire on Dividends: 5 High-Yield Stocks Boomers Are Buying and Holding Forever

What State Street Health Care SPDR (XLV) Bought: Eli Lilly Leads on Oct. 26

AbbVie (ABBV) Expected to Post Quarterly Earnings on Friday - Zolmax

AbbVie Inc. $ABBV Stock Holdings Lowered by Penobscot Investment Management Company Inc. - Stock Observer

Victory Financial Group LLC Buys 2,768 Shares of AbbVie Inc. $ABBV - Daily Political

Why AbbVie's next wave of blockbuster drugs has me buying the stock

Pharmaceutical Stocks To Research - October 27th - Zolmax

Biotech Stocks To Watch Now - October 27th - Markets Daily

AbbVie Inc. $ABBV Shares Newly Bought by Sunesis Advisors LLC - Zolmax

2,729 AbbVie Inc. $ABBV Shares Sold by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA - Markets Daily

AbbVie Submits FDA Application For Etentamig In Multiple Myeloma

Geneva Partners LLC Makes New $3.12 Million Investment in AbbVie Inc. $ABBV - Zolmax

Oppenheimer & Co. Inc. Buys 14,115 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Purchased by Verdence Capital Advisors LLC

Sunesis Advisors LLC Acquires 9,159 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Miller Howard Investments Inc. NY

Leo Wealth LLC Acquires New Shares in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Newly Bought by Geneva Partners LLC

10,800 AbbVie Inc. $ABBV Shares Sold by Hourglass Capital LLC - Markets Daily

Hourglass Capital LLC Sells 10,800 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Hilton Head Capital Partners LLC

Baveno VIII refines the continuum of advanced chronic liver disease and portal hypertension

How Do You Tell a Yield Trap From a Real $6,400-a-Month Dividend Portfolio?

AbbVie Options Price In a Sudden 5% Swing-What Investors Must Know Before Oct. 30

AbbVie Inc. $ABBV Stake Lowered by Robeco Schweiz AG

2,429 AbbVie Inc. $ABBV Shares Sold by Robeco Schweiz AG

AbbVie Inc. $ABBV Stock: Total Wealth Planning & Management Inc. Trims Position

4,457 AbbVie Inc. $ABBV Shares Acquired by Simplicity Wealth LLC

3,545 AbbVie Inc. $ABBV Shares Purchased by IRON Financial LLC

BG Investment Services LLC Acquires 6,371 Shares of AbbVie Inc. $ABBV

Avalo Therapeutics (NASDAQ:AVTX) Stock Gets Price Target Trim from Wedbush - Zolmax

Avalo Therapeutics (NASDAQ:AVTX) Stock Gets Price Target Reduction from BTIG Research - Markets Daily

Erste Group Bank Has Negative View of AbbVie FY2027 Earnings

AbbVie Inc. $ABBV Shares Sold by Middleton & Co. Inc. MA - Daily Political

Teva (TEVA) Gets a Buy from Piper Sandler

AbbVie Inc. $ABBV Stake Boosted by One Wealth Capital Management LLC - Zolmax

AbbVie Inc. $ABBV Holdings Raised by One Wealth Capital Management LLC

AbbVie Inc. $ABBV Stake Lessened by Sterling Capital Management LLC

AbbVie Inc. $ABBV Stock: Evergreen Capital Management LLC Grows Stake

AbbVie Inc. $ABBV Stock Sold by Capital Investment Advisors LLC

AbbVie Inc. $ABBV Holdings Lessened by Wedbush Securities Inc. - Stock Observer

AbbVie Inc. $ABBV Stock Position Boosted by Royal Fund Management LLC

AbbVie Inc. $ABBV Stock: Sepio Capital LP Boosts Position

49,252 Shares in AbbVie Inc. $ABBV Bought by NBT Bank N.A.

AbbVie Inc. $ABBV Stock Bought by Root Financial Partners LLC - Daily Political

AbbVie Inc. (NYSE:ABBV) Stock Has Average Price Target of $279.86

AbbVie's Dividend Survived Humira's Patent Cliff. Will Merck and Amgen's?

Forget Chasing 7% Yields: These 5 Dividend Stocks Offer Something Different